ID   PDE6A_HUMAN             Reviewed;         860 AA.
AC   P16499; Q0P638;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 4.
DT   12-APR-2017, entry version 167.
DE   RecName: Full=Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha;
DE            Short=GMP-PDE alpha;
DE            EC=3.1.4.35;
DE   AltName: Full=PDE V-B1;
DE   Flags: Precursor;
GN   Name=PDE6A; Synonyms=PDEA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2155175; DOI=10.1016/0888-7543(90)90567-E;
RA   Pittler S.J., Baehr W., Wasmuth J.J., McConnell D.G., Champagne M.S.,
RA   VanTuinen P., Ledbetter D., Davis R.L.;
RT   "Molecular characterization of human and bovine rod photoreceptor cGMP
RT   phosphodiesterase alpha-subunit and chromosomal localization of the
RT   human gene.";
RL   Genomics 6:272-283(1990).
RN   [2]
RP   SEQUENCE REVISION TO 846-849.
RA   Pittler S.J., Baehr W., Wasmuth J.J., McConnell D.G., Champagne M.S.,
RA   Vantuinen P., Ledbetter D., Davis R.L.;
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT RP43 ARG-344.
RX   PubMed=7493036; DOI=10.1038/ng1295-468;
RA   Huang S.H., Pittler S.J., Huang X., Oliveira L., Berson E.L.,
RA   Dryja T.P.;
RT   "Autosomal recessive retinitis pigmentosa caused by mutations in the
RT   alpha subunit of rod cGMP phosphodiesterase.";
RL   Nat. Genet. 11:468-471(1995).
RN   [6]
RP   VARIANTS RP43 HIS-102; SER-102; LYS-569 AND PRO-573, AND VARIANTS
RP   SER-216; ALA-277; LEU-293; MET-391; GLN-827 AND VAL-850.
RX   PubMed=10393062;
RA   Dryja T.P., Rucinski D.E., Chen S.H., Berson E.L.;
RT   "Frequency of mutations in the gene encoding the alpha subunit of rod
RT   cGMP-phosphodiesterase in autosomal recessive retinitis pigmentosa.";
RL   Invest. Ophthalmol. Vis. Sci. 40:1859-1865(1999).
CC   -!- FUNCTION: This protein participates in processes of transmission
CC       and amplification of the visual signal.
CC   -!- CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =
CC       guanosine 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000250};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000250};
CC   -!- SUBUNIT: Oligomer composed of two catalytic chains (alpha and
CC       beta), an inhibitory chain (gamma) and the delta chain.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}.
CC   -!- DISEASE: Retinitis pigmentosa 43 (RP43) [MIM:613810]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:10393062,
CC       ECO:0000269|PubMed:7493036}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/pdemut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26061; AAB69155.1; -; mRNA.
DR   EMBL; CH471062; EAW61757.1; -; Genomic_DNA.
DR   EMBL; BC035909; AAH35909.1; -; mRNA.
DR   CCDS; CCDS4299.1; -.
DR   PIR; B34611; B34611.
DR   RefSeq; NP_000431.2; NM_000440.2.
DR   UniGene; Hs.567314; -.
DR   ProteinModelPortal; P16499; -.
DR   BioGrid; 111171; 4.
DR   STRING; 9606.ENSP00000255266; -.
DR   BindingDB; P16499; -.
DR   ChEMBL; CHEMBL3878; -.
DR   DrugBank; DB00201; Caffeine.
DR   GuidetoPHARMACOLOGY; 1312; -.
DR   iPTMnet; P16499; -.
DR   PhosphoSitePlus; P16499; -.
DR   BioMuta; PDE6A; -.
DR   DMDM; 215274230; -.
DR   EPD; P16499; -.
DR   PaxDb; P16499; -.
DR   PeptideAtlas; P16499; -.
DR   PRIDE; P16499; -.
DR   Ensembl; ENST00000255266; ENSP00000255266; ENSG00000132915.
DR   GeneID; 5145; -.
DR   KEGG; hsa:5145; -.
DR   UCSC; uc003lrg.4; human.
DR   CTD; 5145; -.
DR   DisGeNET; 5145; -.
DR   GeneCards; PDE6A; -.
DR   GeneReviews; PDE6A; -.
DR   HGNC; HGNC:8785; PDE6A.
DR   HPA; HPA016970; -.
DR   MalaCards; PDE6A; -.
DR   MIM; 180071; gene.
DR   MIM; 613810; phenotype.
DR   neXtProt; NX_P16499; -.
DR   OpenTargets; ENSG00000132915; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA33133; -.
DR   eggNOG; KOG3689; Eukaryota.
DR   eggNOG; ENOG410XRI7; LUCA.
DR   GeneTree; ENSGT00760000119066; -.
DR   HOGENOM; HOG000007069; -.
DR   HOVERGEN; HBG053539; -.
DR   KO; K08718; -.
DR   OMA; FAKQYYN; -.
DR   OrthoDB; EOG091G01RK; -.
DR   PhylomeDB; P16499; -.
DR   TreeFam; TF316499; -.
DR   Reactome; R-HSA-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   ChiTaRS; PDE6A; human.
DR   GeneWiki; PDE6A; -.
DR   GenomeRNAi; 5145; -.
DR   PMAP-CutDB; P16499; -.
DR   PRO; PR:P16499; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000132915; -.
DR   CleanEx; HS_PDE6A; -.
DR   ExpressionAtlas; P16499; baseline and differential.
DR   Genevisible; P16499; HS.
DR   GO; GO:0097381; C:photoreceptor disc membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IMP:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046037; P:GMP metabolic process; IMP:BHF-UCL.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IMP:BHF-UCL.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF_dom-like.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR032958; PDE6A.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   PANTHER; PTHR11347:SF140; PTHR11347:SF140; 1.
DR   Pfam; PF01590; GAF; 2.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 2.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55781; SSF55781; 3.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; cGMP; Complete proteome; Disease mutation;
KW   Hydrolase; Lipoprotein; Membrane; Metal-binding; Methylation;
KW   Polymorphism; Prenylation; Reference proteome; Repeat;
KW   Retinitis pigmentosa; Sensory transduction; Vision.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P11541}.
FT   CHAIN         2    857       Rod cGMP-specific 3',5'-cyclic
FT                                phosphodiesterase subunit alpha.
FT                                /FTId=PRO_0000198828.
FT   PROPEP      858    860       Removed in mature form. {ECO:0000250}.
FT                                /FTId=PRO_0000396697.
FT   DOMAIN       73    222       GAF 1.
FT   DOMAIN      254    431       GAF 2.
FT   ACT_SITE    559    559       Proton donor. {ECO:0000250}.
FT   METAL       563    563       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       599    599       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       600    600       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       600    600       Divalent metal cation 2. {ECO:0000250}.
FT   METAL       720    720       Divalent metal cation 1. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylglycine.
FT                                {ECO:0000250|UniProtKB:P11541}.
FT   MOD_RES     857    857       Cysteine methyl ester. {ECO:0000250}.
FT   LIPID       857    857       S-farnesyl cysteine. {ECO:0000250}.
FT   VARIANT     102    102       R -> H (in RP43; dbSNP:rs750539462).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025460.
FT   VARIANT     102    102       R -> S (in RP43; dbSNP:rs141252097).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025461.
FT   VARIANT     145    145       A -> T (in dbSNP:rs35431421).
FT                                /FTId=VAR_047730.
FT   VARIANT     216    216       N -> S (in dbSNP:rs10057110).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025462.
FT   VARIANT     277    277       V -> A (in dbSNP:rs145608358).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025463.
FT   VARIANT     293    293       P -> L (in dbSNP:rs114973968).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025464.
FT   VARIANT     344    344       S -> R (in RP43; dbSNP:rs121918577).
FT                                {ECO:0000269|PubMed:7493036}.
FT                                /FTId=VAR_006049.
FT   VARIANT     391    391       V -> M (in dbSNP:rs61732059).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025465.
FT   VARIANT     492    492       Q -> H (in dbSNP:rs17711594).
FT                                /FTId=VAR_047731.
FT   VARIANT     569    569       Q -> K (in RP43; dbSNP:rs139444207).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025466.
FT   VARIANT     573    573       S -> P (in RP43; dbSNP:rs755527251).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025467.
FT   VARIANT     827    827       K -> Q (in dbSNP:rs780450680).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025468.
FT   VARIANT     850    850       G -> V (in dbSNP:rs138315990).
FT                                {ECO:0000269|PubMed:10393062}.
FT                                /FTId=VAR_025469.
FT   CONFLICT    224    224       V -> W (in Ref. 1; AAB69155).
FT                                {ECO:0000305}.
SQ   SEQUENCE   860 AA;  99547 MW;  7EEA48A234C1FE59 CRC64;
     MGEVTAEEVE KFLDSNIGFA KQYYNLHYRA KLISDLLGAK EAAVDFSNYH SPSSMEESEI
     IFDLLRDFQE NLQTEKCIFN VMKKLCFLLQ ADRMSLFMYR TRNGIAELAT RLFNVHKDAV
     LEDCLVMPDQ EIVFPLDMGI VGHVAHSKKI ANVPNTEEDE HFCDFVDILT EYKTKNILAS
     PIMNGKDVVA IIMAVNKVDG SHFTKRDEEI LLKYLNFANL IMKVYHLSYL HNCETRRGQI
     LLWSGSKVFE ELTDIERQFH KALYTVRAFL NCDRYSVGLL DMTKQKEFFD VWPVLMGEVP
     PYSGPRTPDG REINFYKVID YILHGKEDIK VIPNPPPDHW ALVSGLPAYV AQNGLICNIM
     NAPAEDFFAF QKEPLDESGW MIKNVLSMPI VNKKEEIVGV ATFYNRKDGK PFDEMDETLM
     ESLTQFLGWS VLNPDTYESM NKLENRKDIF QDIVKYHVKC DNEEIQKILK TREVYGKEPW
     ECEEEELAEI LQAELPDADK YEINKFHFSD LPLTELELVK CGIQMYYELK VVDKFHIPQE
     ALVRFMYSLS KGYRKITYHN WRHGFNVGQT MFSLLVTGKL KRYFTDLEAL AMVTAAFCHD
     IDHRGTNNLY QMKSQNPLAK LHGSSILERH HLEFGKTLLR DESLNIFQNL NRRQHEHAIH
     MMDIAIIATD LALYFKKRTM FQKIVDQSKT YESEQEWTQY MMLEQTRKEI VMAMMMTACD
     LSAITKPWEV QSQVALLVAA EFWEQGDLER TVLQQNPIPM MDRNKADELP KLQVGFIDFV
     CTFVYKEFSR FHEEITPMLD GITNNRKEWK ALADEYDAKM KVQEEKKQKQ QSAKSAAAGN
     QPGGNPSPGG ATTSKSCCIQ
//
